ARCHIVES

Bayer’s HER-2/neu Blood Test Cleared By FDA For Marketing.

This article is from The Cancer Letter archive.

Vol. 26 No. 46 | December 15, 2000

Download PDF Visit The Full Archive

Related Articles

In Brief: BCDDP “Dramatically” Changed U.S. Medical Practice, Fink Says; *% Not too uch-DeVita

December 15, 1978

HHS Carcinogen Guidelines Draft

June 6, 1980

FASEB Urges Better Funding, Management Of Biomedical Research

February 23, 1996

NCI Staff Recommends Moving Cooperative Groups Into DCT, Increase Funding, Switch Emphasis

July 4, 1975

Afinitor and Sutent Approved For Pancreatic Neuroendocrine Tumors

May 27, 2011

Hilton Head, SC, Physician’s Files Subpoenaed By FBI

March 18, 1994